About Hospital General de Culiacán
Clinical Trials at Hospital General de Culiacán
During the past decade, Hospital General de Culiacán conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital General de Culiacán" #1 sponsor was "Corvus Pharmaceuticals, Inc." with 1 trials, followed by "Genentech, Inc." with 1 trials
sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Shenyang Tonglian Group CO., Ltd" with 1 trials sponsored and "Veru Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Culiacán"
#1 collaborator was "AbbVie" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital General de Culiacán
According to Clinical.Site data, the most researched conditions in "Hospital General de Culiacán" are
"COVID-19 Pneumonia" (1 trials), "Coronavirus Disease 2019" (1 trials), "Covid-19" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "SARS-CoV Infection" (1 trials). Many other conditions were trialed in "Hospital General de Culiacán" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General de Culiacán
Most popular intervention types in "Hospital General de Culiacán" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "CPI-006 1 mg/kg + SOC" (1 trials), "CPI-006 2 mg/kg + SOC" (1 trials), "Carrimycin" (1 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General de Culiacán
The vast majority of trials in "Hospital General de Culiacán" are
5 trials for "All" genders.
Clinical Trials Status at Hospital General de Culiacán
Currently, there are NaN active trials in "Hospital General de Culiacán".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital General de Culiacán,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General de Culiacán, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".